Avilex Pharma

Avilex Pharma develops novel inhibitors of PDZ domain proteins to target a range of unmet medical needs with a lead drug candidate AVLX-144 for the treatment of ischemic stroke.

Contact name:

Kristian Strømgaard


Ole Maaløes Vej 3, 2200 Copenhagen N, Denmark

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2015 Danskbiotek. All rights reserved.